Clinical Trial Update: Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of cisplatin, docetaxel, and nintedanib given before surgery in patients with previously untreated stage IB-IIIA non-sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• Nintedanib (nintedanib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7 | Phase 1 | Status: COMPLETED